RC
DGX icon

Roundview Capital’s Quest Diagnostics DGX Stock Holding History

Roundview Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.45M Hold
7,422
– – 0.09% 183
2025
Q4 		$1.29M Sell
7,422
-1,690
-19% -$308K 0.08% 192
2025
Q3 		$1.74M Sell
9,112
-72
-0.8% -$12.8K 0.11% 164
2025
Q2 		$1.65M Sell
9,184
-14
-0.2% -$2.43K 0.11% 167
2025
Q1 		$1.56M Sell
9,198
-969
-10% -$159K 0.11% 162
2024
Q4 		$1.53M Buy
10,167
+90
+0.9% +$14K 0.11% 172
2024
Q3 		$1.56M Buy
10,077
+119
+1% +$17.8K 0.11% 170
2024
Q2 		$1.36M Sell
9,958
-609
-6% -$83.4K 0.11% 172
2024
Q1 		$1.41M Sell
10,567
-111
-1% -$14.4K 0.12% 171
2023
Q4 		$1.47M Sell
10,678
-225
-2% -$29.6K 0.14% 151
2023
Q3 		$1.33M Hold
10,903
– – 0.13% 155
2023
Q2 		$1.53M Buy
10,903
+284
+3% +$39.2K 0.15% 142
2023
Q1 		$1.5M Buy
10,619
+102
+1% +$14.6K 0.16% 145
2022
Q4 		$1.65M Buy
10,517
+518
+5% +$74.4K 0.19% 133
2022
Q3 		$1.23M Buy
9,999
+754
+8% +$99.3K 0.15% 143
2022
Q2 		$1.23M Sell
9,245
-74
-0.8% -$10.1K 0.15% 149
2022
Q1 		$1.27M Buy
9,319
+42
+0.5% +$5.85K 0.13% 156
2021
Q4 		$1.6M Buy
9,277
+1,031
+13% +$157K 0.16% 144
2021
Q3 		$1.2M Buy
8,246
+578
+8% +$84.6K 0.13% 163
2021
Q2 		$1.01M Buy
7,668
+365
+5% +$47.8K 0.11% 181
2021
Q1 		$937K Buy
7,303
+45
+0.6% +$5.54K 0.12% 173
2020
Q4 		$865K Buy
7,258
+60
+0.8% +$7.31K 0.12% 167
2020
Q3 		$824K Buy
7,198
+73
+1% +$8.63K 0.13% 149
2020
Q2 		$812K Buy
+7,125
New +$756K 0.14% 155
2015
Q4 		– Sell
-16,901
Closed -$1.04M – 165
2015
Q3 		$1.04M Buy
+16,901
New +$1.18M 0.45% 65

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Roundview Capital's DGX Position: Q1 2026 in Review

Roundview Capital held its Quest Diagnostics (DGX) position steady in Q1 2026 at 7,422 shares worth $1.45M. The position accounts for 0.09% of the portfolio, ranked #183.

Roundview Capital first reported a position in DGX in Q3 2015 and has held it in 25 quarters since. The position peaked at $1.74M in Q3 2025. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Roundview Capital held 7,422 shares of Quest Diagnostics worth $1.45M as of Q1 2026.
  • Roundview Capital left its Quest Diagnostics share count unchanged in Q1 2026.
  • Quest Diagnostics made up 0.09% of Roundview Capital's portfolio in Q1 2026, its #183 holding.
  • Roundview Capital first reported a position in Quest Diagnostics in Q3 2015 and has held it in 25 quarters since.
  • Roundview Capital's Quest Diagnostics position peaked at $1.74M in Q3 2025.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Roundview Capital's 13F filing for Q1 2026, filed 8 May 2026.